• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Misoprostol Administration Before Hysteroscopy Procedures - A Retrospective Analysis.宫腔镜检查术前应用米索前列醇的回顾性分析。
Rev Bras Ginecol Obstet. 2022 Dec;44(12):1102-1109. doi: 10.1055/s-0042-1755462. Epub 2022 Aug 29.
2
[Sublingual Misoprostol for cervical ripening before diagnostic hysteroscopy: a randomized and prospective study about 108 cases].[舌下含服米索前列醇用于诊断性宫腔镜检查前宫颈成熟:一项关于108例患者的随机前瞻性研究]
Tunis Med. 2011 Nov;89(11):825-9.
3
Misoprostol for cervical priming prior to hysteroscopy in postmenopausal and premenopausal nulliparous women; a multicentre randomised placebo controlled trial.米索前列醇用于绝经后和绝经前未产妇女宫腔镜检查前宫颈预处理:一项多中心随机安慰剂对照试验。
BJOG. 2018 Jan;125(1):81-89. doi: 10.1111/1471-0528.14567. Epub 2017 Mar 3.
4
Use of misoprostol prior to hysteroscopy in postmenopausal women: a randomized, placebo-controlled clinical trial.绝经后女性宫腔镜检查前使用米索前列醇:一项随机、安慰剂对照临床试验。
J Minim Invasive Gynecol. 2008 Jan-Feb;15(1):67-73. doi: 10.1016/j.jmig.2007.08.596.
5
Use of Oral Misoprostol for Cervical Priming before Hysteroscopy: A Randomized Comparison of Two Dosages.宫腔镜检查前口服米索前列醇用于宫颈准备:两种剂量的随机对照比较
Gynecol Obstet Invest. 2016;81(4):333-8. doi: 10.1159/000441785. Epub 2015 Nov 21.
6
A randomised placebo-controlled trial of vaginal misoprostol for cervical priming before hysteroscopy in postmenopausal women.绝经后妇女宫腔镜检查前阴道用米索前列醇进行宫颈准备的随机安慰剂对照试验。
BJOG. 2002 May;109(5):561-5. doi: 10.1111/j.1471-0528.2002.01054.x.
7
Use of misoprostol before hysteroscopy: a systematic review.宫腔镜检查前米索前列醇的应用:一项系统评价
J Obstet Gynaecol Can. 2006 May;28(5):373-9. doi: 10.1016/s1701-2163(16)32150-8.
8
Sublingual versus vaginal misoprostol for cervical ripening before hysteroscopy: a randomized clinical trial.舌下与阴道给予米索前列醇用于宫腔镜检查前宫颈成熟:一项随机临床试验。
Arch Gynecol Obstet. 2013 May;287(5):937-40. doi: 10.1007/s00404-012-2652-4. Epub 2012 Dec 4.
9
Comparison of self-administered vaginal misoprostol versus placebo for cervical ripening prior to operative hysteroscopy using a sequential trial design.采用序贯试验设计比较自我给药米索前列醇与安慰剂用于宫腔镜手术前宫颈成熟的效果。
BJOG. 2008 Apr;115(5):663, e1-9. doi: 10.1111/j.1471-0528.2007.01628.x. Epub 2008 Jan 16.
10
Effectiveness of misoprostol administration for cervical ripening in women before operative hysteroscopy: a randomized, double-blinded controlled trial.米索前列醇用于宫腔镜手术前女性宫颈成熟的有效性:一项随机双盲对照试验。
Minim Invasive Ther Allied Technol. 2019 Dec;28(6):344-350. doi: 10.1080/13645706.2018.1559195. Epub 2019 Mar 25.

引用本文的文献

1
Assessing the Efficacy and Safety of Misoprostol Prior to Hysteroscopy in Women with Difficult Cervix: A Systematic Review and Meta-Analysis.评估米索前列醇在宫颈坚硬女性宫腔镜检查前的疗效和安全性:一项系统评价和荟萃分析。
J Clin Med. 2024 Sep 17;13(18):5494. doi: 10.3390/jcm13185494.

本文引用的文献

1
Cervical dilatation and preparation prior to outpatient hysteroscopy: a systematic review and meta-analysis.门诊宫腔镜检查前的宫颈扩张与准备:一项系统评价与荟萃分析
BJOG. 2021 Jun;128(7):1112-1123. doi: 10.1111/1471-0528.16604. Epub 2020 Dec 6.
2
Use of misoprostol in the treatment of postpartum hemorrhage: a pharmacoepidemiological approach.米索前列醇在产后出血治疗中的应用:一种药物流行病学方法。
Einstein (Sao Paulo). 2019 Nov 7;18:eAO5029. doi: 10.31744/einstein_journal/2020AO5029. eCollection 2020.
3
Misoprostol Prior to Diagnostic Office Hysteroscopy in the Subgroup of Patients with No Risk Factors for Cervical Stenosis: A Randomized Double Blind Placebo-Controlled Trial.在无宫颈狭窄危险因素的患者亚组中,诊断性宫腔镜检查前使用米索前列醇:一项随机双盲安慰剂对照试验。
Gynecol Obstet Invest. 2018;83(5):455-460. doi: 10.1159/000480234. Epub 2017 Oct 6.
4
Different Routes of Misoprostol for Same-Day Cervical Priming Prior to Operative Hysteroscopy: A Randomized Blinded Trial.宫腔镜手术前米索前列醇当日宫颈准备的不同给药途径:一项随机双盲试验
J Minim Invasive Gynecol. 2017 Mar-Apr;24(3):455-460. doi: 10.1016/j.jmig.2016.12.024. Epub 2017 Jan 7.
5
A systematic review and meta-analysis of randomized controlled trials on the effectiveness of cervical ripening with misoprostol administration before hysteroscopy.米索前列醇用于宫腔镜检查前宫颈成熟度有效性的随机对照试验的系统评价和荟萃分析。
Int J Gynaecol Obstet. 2016 Mar;132(3):272-7. doi: 10.1016/j.ijgo.2015.07.039. Epub 2015 Dec 11.
6
Effectiveness of different routes of misoprostol administration before operative hysteroscopy: a randomized, controlled trial.宫腔镜手术前不同途径给予米索前列醇的有效性:一项随机对照试验
Fertil Steril. 2014 Aug;102(2):519-24. doi: 10.1016/j.fertnstert.2014.04.040. Epub 2014 May 23.
7
Cervical priming before diagnostic operative hysteroscopy in infertile women: a randomized, double-blind, controlled comparison of 2 vaginal misoprostol doses.不孕女性诊断性宫腔镜手术前的宫颈准备:两种米索前列醇阴道给药剂量的随机、双盲、对照比较
Int Surg. 2013 Apr-Jun;98(2):140-4. doi: 10.9738/INTSURG-D-12-00024.1.
8
Misoprostol in operative hysteroscopy: a systematic review and meta-analysis.米索前列醇在宫腔镜手术中的应用:系统评价和荟萃分析。
Obstet Gynecol. 2011 Oct;118(4):941-9. doi: 10.1097/AOG.0b013e31822f3c7b.
9
Uses of misoprostol in obstetrics and gynecology.米索前列醇在妇产科的应用。
Rev Obstet Gynecol. 2009 Summer;2(3):159-68.
10
[Hysteroscopy in menopause: analysis of the techniques and accuracy of the method].[更年期宫腔镜检查:技术分析及方法准确性]
Rev Bras Ginecol Obstet. 2008 Oct;30(10):524-30. doi: 10.1590/s0100-72032008001000008.

宫腔镜检查术前应用米索前列醇的回顾性分析。

Misoprostol Administration Before Hysteroscopy Procedures - A Retrospective Analysis.

机构信息

Departamento de Ginecologia e Obstetrícia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.

出版信息

Rev Bras Ginecol Obstet. 2022 Dec;44(12):1102-1109. doi: 10.1055/s-0042-1755462. Epub 2022 Aug 29.

DOI:10.1055/s-0042-1755462
PMID:36037813
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9800141/
Abstract

OBJECTIVE

To evaluate the use of misoprostol prior to hysteroscopy procedures regarding technical ease, the presence of side effects, and the occurrence of complications.

METHODS

This is a retrospective, observational, analytical, case-control study, with the review of medical records of 266 patients followed-up at the Gynecological Videoendoscopy Sector of the Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto of the Universidade de São Paulo (HCFMRP - USP, in the Portuguese acronym) from 2014 to 2019, comparing 133 patients who used the drug before the procedure with 133 patients who did not.

RESULTS

The occurrence of postmenopausal uterine bleeding was the main indication for hysteroscopy and revealed a statistical difference between groups ( < 0.001), being present in 93.23% of the patients in the study group and in 69.7% of the patients in the control group.: Only 2 patients (1.5%) in the study group reported adverse effects. Although no statistical differences were observed regarding the occurrence of complications during the procedure ( = 0.0662), a higher total number of complications was noted in the group that used misoprostol ( = 7; 5.26%) compared with the group that did not use the drug ( = 1; 0.75%), a fact that is clinically relevant. When evaluating the ease of the technique (measured by the complete performance of all steps of the hysteroscopy procedure), it was verified that although there was no difference between groups ( = 0.0586), the control group had more than twice as many incompletely performed procedures ( = 17) when compared with the group that used misoprostol previously ( = 8), which is also clinically relevant.

CONCLUSION

The use of misoprostol prior to hysteroscopy in our service indicated that the drug can facilitate the performance of the procedure, but not without side effects and presenting higher complication rates.

摘要

目的

评估在宫腔镜检查前使用米索前列醇对技术难度、副作用的发生以及并发症的发生的影响。

方法

这是一项回顾性、观察性、分析性病例对照研究,对 2014 年至 2019 年在圣保罗大学里贝朗普雷托医学院附属医院妇科内镜科接受治疗的 266 名患者的病历进行了回顾,将 133 名在检查前使用该药物的患者与 133 名未使用该药物的患者进行了比较。

结果

绝经后子宫出血是进行宫腔镜检查的主要指征,且组间存在统计学差异( < 0.001),研究组中有 93.23%的患者存在该症状,而对照组中则有 69.7%的患者存在该症状。仅 2 名(1.5%)研究组患者报告出现不良反应。尽管在手术过程中发生并发症的发生率方面未观察到统计学差异( = 0.0662),但使用米索前列醇的组( = 7;5.26%)的总并发症数量高于未使用药物的组( = 1;0.75%),这在临床上是相关的。当评估技术的难易程度(通过宫腔镜检查程序的所有步骤的完全执行情况来衡量)时,虽然组间无差异( = 0.0586),但与使用米索前列醇的组( = 8)相比,未使用药物的组( = 17)有更多未完全执行的程序,这在临床上也是相关的。

结论

在我们的服务中,在宫腔镜检查前使用米索前列醇表明该药物可以促进手术的进行,但并非没有副作用,且并发症发生率更高。